Posted by john on March 30th, 2007 — in Celebrex Top News
The controversial arthritis pain pill Celebrex could return to television in new ads by this summer pending negotiations under way between the drug’s maker, Pfizer Inc., and the Food and Drug Administration.
Pfizer agreed to pull ads for Celebrex in the wake of the Vioxx imbroglio and just before of an FDA advisory panel said the […]
No Comments »
Posted by john on March 27th, 2007 — in Celebrex Top News
CHICAGO — Given the option of living with pain or an increased heart attack risk, some Baby Boomers are assuming the risk and going back to a drug still considered potentially dangerous by the government.
Two years after Vioxx and other powerful arthritis pain fighters were linked to cardiovascular trouble, there is a big comeback under […]
3 Comments »
Posted by john on March 23rd, 2007 — in Celebrex Top News
A federal court has ruled that three main patents for Pfizer’s Celebrex are valid until 2015.
The threat of generic competition to Celebrex has diminished after patents covering the drug were upheld. Teva will not be allowed to file for a copycat version of the drug until 2015 and other generics manufacturers are now unlikely to […]
No Comments »
Posted by john on March 17th, 2007 — in Celebrex Top News
Millions of Americans suffer from back pain, but could Botox be the answer. Now the same stuff that is used to get rid of wrinkles is being used at Scripps La Jolla to give patients relief from chronic back pain.
Hank Coleman loves to surf, but chronic back pain is keeping him out of the water.
“I […]
2 Comments »
Posted by john on March 13th, 2007 — in Celebrex Top News
The Tennessee woman wrote to the Food and Drug Administration, brokenhearted and mystified.
Her 66-year-old husband had taken Celebrex for arm and back pain. They talked, over coffee, about overgrown trees that needed trimming. It was their last conversation.
That day, the man suffered a stroke, robbing him of his speech and independence.
“He was like a child,” […]
No Comments »
Posted by john on March 11th, 2007 — in Celebrex Top News
Handling the bloating, cramping and heightened stress that comes with PMS is about to get a lot easier and and sweet-smelling.
One PMS sufferer, Tricia Northam, said nothing really treated the tired and tender symptoms. So her doctor recommended aromatherapy for PMS.
Essential oils, in their purest form, are tailor-made to each person’s symptoms. Some of the […]
1 Comment »
Posted by john on March 6th, 2007 — in Celebrex Top News
Deciding which medicine to give a child in pain just got easier: The first head-to-head study of three common painkillers found that ibuprofen works best, at least for kids with broken bones, bruises and sprains.
Available generically and under the brand names Advil and Motrin, ibuprofen beat generic acetaminophen and codeine in an emergency room study […]
2 Comments »
Posted by john on March 2nd, 2007 — in Celebrex Top News
MAP Pharmaceuticals, Inc. announced today that its Tempo(TM) Migraine drug candidate met its primary endpoints in a Phase 2 clinical program consisting of two separate trials. The candidate is a proprietary orally inhaled formulation of dihydroergotamine (DHE) for the treatment of acute migraine.
The first Phase 2 study demonstrated clinically significant results in a randomized, outpatient, […]
No Comments »